Advertisement

Health


FDA fast tracks Mesoblast COVID-19 treatment

FDA fast tracks Mesoblast COVID-19 treatment

A COVID-19 treatment being developed by Australian pharmaceutical...

Viva Leisure raises $30m to pump up as gym junkies return in droves

Viva Leisure raises $30m to pump up as gym junkies return in droves

As gym junkies return in droves to its centres, Viva Leisure (ASX: ...

Mesoblast, Novartis sign commercialisation deal for COVID-19 treatment

Mesoblast, Novartis sign commercialisation deal for COVID-19 treatment

Australian pharmaceutical company Mesoblast (ASX: MSB) has penned...

Pfizer COVID-19 vaccine now 95 per cent effective

Pfizer COVID-19 vaccine now 95 per cent effective

A COVID-19 vaccine candidate being developed by US pharmaceutical...

Class action "the only hope" for Smiles Inclusive partners on the sidelines

Class action "the only hope" for Smiles Inclusive partners on the sidelines

Smiles Inclusive (ASX: SIL) joint venture partners (JVPs) have ha...

Advertisement
Advertisement
Advertisement
CSL to build $800m flu vaccine facility in Melbourne

CSL to build $800m flu vaccine facility in Melbourne

Australia-headquartered CSL (ASX: CSL) is set to bring a cell-bas...

UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon

UQ COVID-19 vaccine "ahead of schedule", Phase 3 trials to commence soon

A COVID-19 vaccine being developed by the University of Queenslan...

Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500

Restrictions on ACT venues to ease tomorrow, patron cap will increase to 500

The improving COVID-19 situation in Victoria and New South Wales ...

Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed

Mesoblast rebounds on COVID-19 treatment update, puts vaccine concerns to bed

Melbourne-based med-tech company Mesoblast (ASX: MSB) has rebound...

Health fund backs medicinal cannabis with Little Green Pharma deal

Health fund backs medicinal cannabis with Little Green Pharma deal

Little Green Pharma (ASX: LGP) hopes a new strategic partnership ...

Smiles Inclusive enters voluntary administration

Smiles Inclusive enters voluntary administration

The local anaesthetic of turnaround promises has finally wor...

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

MedAdvisor to buy USA's largest patient-prescriber network Adheris for $49m

Medical software group MedAdvisor (ASX: MDR) is prepared to ...

Healthia to buy The Optical Company for $43 million

Healthia to buy The Optical Company for $43 million

Just one day after announcing yet another spending spree, allied ...

Atomo's COVID-19 nasal swab test gets green light from TGA

Atomo's COVID-19 nasal swab test gets green light from TGA

Sydney-based Atomo Diagnostics (ASX: AT1) has yet another feather...

Noxopharm starts trial in COVID-19 treatment race

Noxopharm starts trial in COVID-19 treatment race

Burgeoning medtech company Noxopharm (ASX: NOX) is making strides...

NAB tightens the screws on Smiles Inclusive

NAB tightens the screws on Smiles Inclusive

Smiles Inclusive (ASX: SIL) has been given a slight reprieve on a...

CSL seals deal to supply 51 million doses of UQ COVID-19 vaccine candidate

CSL seals deal to supply 51 million doses of UQ COVID-19 vaccine candidate

Biotechnology giant CSL (ASX: CSL) has finalised an agreement wit...

Mesoblast plunges as FDA orders additional trial of Ryoncil

Mesoblast plunges as FDA orders additional trial of Ryoncil

Shares in Mesoblast (ASX: MSB) were down 40 per cent this morning...

Starpharma raises $45 million to launch COVID-19 nasal spray

Starpharma raises $45 million to launch COVID-19 nasal spray

Listed pharmaceutical company Starphrama (ASX: SPL) has today com...

Global COVID-19 deaths pass one million

Global COVID-19 deaths pass one million

The world has today passed the harrowing milestone of more than o...

Advertisement

Partner Content

The COVID-19 pandemic has fundamentally changed the way Australia...
Curtin University and Extreme Tech Challenge (XTC) have partnere...
Due diligence is paramount for responsible lending, but that does...
After seeing how expensive and time-consuming it was for the mili...
Upskilling was the name of the game when energy specialist Jessie...
After months of limited event activity, the Gold Coast Convention...
There is a real sense of urgency towards technological adoption a...
VIN. For most people it is either the French word for wine, or ...
Sydney-based healthcare company Medicision has announced a n...
The New Payments Platform (NPP) has significantly changed everyda...
Advertisement